Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lexa FJ (1995) Drug-induced disorders of the central nervous system. Seminars in Roentgenol 30:7–17
Brown MS, Stemmer SM, Simon JH, et al. (1998) White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy. AJNR Am J Neuroradiol 19:217–221
Fujikawa A, Tsuchiya K, Katase S, Kurosaki Y, Hachiya J (2001) Diffusion-weighted MR imaging of Carmofur-induced leukoencephalopathy. Eur Radiol 11:2602–2606
Tha KK, Terae S, Sugiura M, et al. (2002) Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta Neurol Scand 106:379–386
Matsumoto S, Nishizawa S, Murakami S, et al. (1995) Carmofur-induced leukoencephalopathy: MRI. Neuroradiology 37:649–652
Maschke M, Fehlings T, Kastrup O, Wilhelm HW, Leonhardt G (1999) Toxic leukoencephalopathy after intravenous consumption of heroin and cocaine with unexpected clinical recovery. J Neurol 246:850–851
Wolters EC, van Wijngaarden GK, Stam FC, et al (1982) Leucoencephalopathy after inhaling “heroin” pyrolysate. Lancet 2:1233–1237
Tan TP, Algra PR, Valk J, Wolters EC (1994) Toxic leukoencephalopathy after inhalation of poisoned heroin: MR findings. Am J Neuroradiol 15:175–178
Chen CY, Lee KW, Lee CC, Chin SC, Chung HW, Zimmerman RA (2000) Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging. J Comput Assist Tomogr 24:735–737
Barnett MH, Miller LA, Reddel SW, Davies L (2001) Reversible delayed leukoencephalopathy following intravenous heroin overdose. J Clin Neurosci 8:165–167
Gocht A, Colmant HJ (1987) Central pontine and extrapontine myelinolysis: a report of 58 cases. Clin Neuropathol 6:262–270
Sterns RH, Riggs JE, Schochet SS Jr (1986) Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med 314:1535–1542
Ho VB, Fitz CR, Yoder CC, Geyer CA (1993) Resolving MR features in osmotic myelinolysis (central pontine and extrapontine myelinolysis. Am J Neuroradiol 14:163–167
Norenberg MD (1983) A hypothesis of osmotic endothelial injury. A pathogenetic mechanism in central pontine myelinolysis. Arch Neurol 40:66–69
Mascalchi M, Cincotta M, Piazzini M (1993) Case report: MRI demonstration of pontine and thalamic myelinolysis in a normonatremic alcoholic. Clin Radiol 47:137–138
Rodriguez J, Benito-Leon J, Molina JA, Ramos A, Bermejo F (1998) Central pontine myelinolysis associated with cyclosporin in liver transplantation. Neurologia 13:437–440
Miller RF, Harrison MJ, Hall-Craggs MA, Scaravilli F (1998) Central pontine myelinolysis in AIDS. Acta Neuropathol 96:537–540
Cramer SC, Stegbauer KC, Schneider A, Mukai J, Maravilla KR (2001) Decreased diffusion in central pontine myelinolysis. AJNR Am J Neuroradiol 22:1476–1479
Anderson AW, Zhong J, Petroff OA, et al (1996) Effects of osmotically driven cell volume changes on diffusion-weighted imaging of the rat optic nerve. Magn Reson Med 35:162–167
Victor M,Adams RD, Collins GH (1971) The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser 7:1–206
Antunez E, Estruch R, Cardenal C, Nicolas JM, Fernandez-Sola J, Urbano-Marquez A (1998) Usefulness of CT and MR imaging in the diagnosis of acute Wernicke’s encephalopathy. AJR Am J Roentgenol 171:1131–1137
Oka M, Terae S, Kobayashi R, et al. (2001) Diffusion-weighted MR findings in a reversible case of acute Wernicke encephalopathy. Acta Neurol Scand 104:178–181
Doherty MJ, Watson NF, Uchino K, Hallam DK, Cramer SC (2002) Diffusion abnormalities in patients with Wernicke encephalopathy. Neurology 58:655–657
Chu K, Kang DW, Kim HJ, Lee YS, Park SH (2002) Diffusion-weighted imaging abnormalities in wernicke encephalopathy: reversible cytotoxic edema? Arch Neurol 59:123–127
Rugilo CA, Roca MC, Zurru MC, Gatto EM (2003) Diffusion abnormalities and Wernicke encephalopathy. Neurology 60:727–728; author reply 727–728
Gambini A, Falini A, Moiola L, Comi G, Scotti G (2003) Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study. Am J Neuroradiol 24:249–253
Gass A, Birtsch G, Olster M, Schwartz A, Hennerici MG (1998) Marchiafava-Bignami disease: reversibility of neuroimaging abnormality. J Comput Assist Tomogr 22:503–504
Inagaki T, Saito K (2000) A case of Marchiafava-Bignami disease demonstrated by MR diffusion-weighted image. No To Shinkei 52:633–637
Oppenheim C, Galanaud D, Samson Y, et al. (2000) Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 69:248–250
Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M (1999) Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 53: 2182–2184
Yonemura K, Hasegawa Y, Kimura K, Minematsu K, Yamaguchi T (2001) Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. AJNR Am J Neuroradiol 22:269–272
Ohshita T, Oka M, Imon Y, et al. (2000) Serial diffusion-weighted imaging in MELAS. Neuroradiology 42:651–656
Kim HS, Kim DI, Lee BI, et al. (2001) Diffusion-weighted image and MR spectroscopic analysis of a case of MELAS with repeated attacks. Yonsei Med J 42:128–133
Majoie CB, Akkerman EM, Blank C, Barth PG, Poll-The BT, den Heeten GJ (2002) Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. AJNR Am J Neuroradiol 23:813–816
Flemming K, Ulmer S, Duisberg B, Hahn A, Jansen O (2002) MR spectroscopic findings in a case of Alpers-Huttenlocher syndrome. AJNR Am J Neuroradiol 23:1421–1423
Huttenlocher PR (2000) The neuropathology of phenylketonuria: human and animal studies. Eur J Pediatr Suppl 2:S102–S106
Pearsen KD, Gean-Marton AD, Levy HL, Davis KR (1990) Phenylketonuria: MR imaging of the brain with clinical correlation. Radiology 177:437–440
Phillips MD, McGraw P, Lowe MJ, Mathews VP, Hainline BE (2001) Diffusion-weighted imaging of white matter abnormalities in patients with phenylketonuria. AJNR Am J Neuroradiol 22:1583–1586
Ono J, Harada K, Mano T, Sakurai K, Okada S (1997) Differentiation of dysand demyelination using diffusional anisotropy. Pediatr Neurol 16:63–66
Engelbrecht V, Scherer A, Rassek M, Witsack HJ, Modder U (2002) Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 222:410–418
Sener RN (2003) Canavan disease: diffusion magnetic resonance imaging findings. J Comput Assist Tomogr 27:30–33
Eichler FS, Itoh R, Barker PB, et al. (2002) Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 225:245–252
Sener RN (2002) Metachromatic leukodystrophy: diffusion MR imaging findings. AJNR Am J Neuroradiol 23:1424–1426
Sener RN (2003) L-2 hydroxyglutaric aciduria: proton magnetic resonance spectroscopy and diffusion magnetic resonance imaging findings. J Comput Assis Tomo 27:38–43
Sener RN (2003) Diffusion magnetic resonance imaging in infantile neuroaxonal dystrophy. J Comput Assis Tomo 27:34–37
Ellison D, Love S (1998) Toxic injury of the CNS. In: Neuropathology, 1st edn, section 8, chapter 25. Barcelona, Mosby, pp 25.1–25.22
Ono J, Harada K, Sakurai K, et al. (1994) MR diffusion imaging in Pelizaeus-Merzbacher disease. Brain Dev 16:219–223
Guo AC, Petrella JR, Kurtzberg J, Provenzale JM (2001) Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience. Radiology 218:809–815
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2005). Toxic and Metabolic Disease. In: Diffusion-Weighted MR Imaging of the Brain. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26386-1_10
Download citation
DOI: https://doi.org/10.1007/3-540-26386-1_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25359-4
Online ISBN: 978-3-540-26386-9
eBook Packages: MedicineMedicine (R0)